Stimulants & ADHD Medications at Psych Congress 2026
3 sessions on stimulants & adhd medications · September 15–19, 2026, New Orleans, LA. Compare stimulants & adhd medications at other meetings →
Wednesday, September 16
Symposium · First-Line Decisions
First-Line Decisions: Lifestyle Modification or Medication? Balancing Pharmacologic and Non-Pharmacologic Care in ADHD
James Greenblatt · Julie Carbray
Guides initial ADHD treatment choices between stimulant/non-stimulant medication and behavioral, coaching, and environmental strategies based on severity, preference, and comorbidity.
Symposium · MasterClass
MasterClass: Features Out of Focus: Recognition and Treatment of Emotional Dysregulation and Executive Dysfunction in ADHD
Gregory Mattingly · Julie Carbray
Highlights emotional dysregulation and executive dysfunction as underrecognized drivers of ADHD impairment, with neurobiological context and emerging pharmacologic options.
Thursday, September 17
Symposium · Women's Mental Health
Women, Hormones, and ADHD: What We Know, What We Don't, and What Clinicians Need to Understand
Gregory Mattingly · Moushumi Mukerji
Evidence-informed overview of how estrogen and progesterone shifts across the menstrual cycle, pregnancy, and perimenopause affect attention, mood, and stimulant response, with prescribing considerations amid research gaps.
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5